282 related articles for article (PubMed ID: 38347839)
1. Application of AI on cholangiocarcinoma.
Huang J; Bai X; Qiu Y; He X
Front Oncol; 2024; 14():1324222. PubMed ID: 38347839
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging.
Liu J; Shu J
Crit Rev Oncol Hematol; 2024 Feb; 194():104235. PubMed ID: 38220125
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence in medical imaging for cholangiocarcinoma diagnosis: A systematic review with scientometric analysis.
Njei B; Kanmounye US; Seto N; McCarty TR; Mohan BP; Fozo L; Navaneethan U
J Gastroenterol Hepatol; 2023 Jun; 38(6):874-882. PubMed ID: 36919223
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence and cholangiocarcinoma: Updates and prospects.
Haghbin H; Aziz M
World J Clin Oncol; 2022 Feb; 13(2):125-134. PubMed ID: 35316928
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
[TBL] [Abstract][Full Text] [Related]
6. Computer auxiliary diagnosis technique of detecting cholangiocarcinoma based on medical imaging: A review.
Wang S; Liu X; Zhao J; Liu Y; Liu S; Liu Y; Zhao J
Comput Methods Programs Biomed; 2021 Sep; 208():106265. PubMed ID: 34311415
[TBL] [Abstract][Full Text] [Related]
7. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence in pancreatic cancer.
Huang B; Huang H; Zhang S; Zhang D; Shi Q; Liu J; Guo J
Theranostics; 2022; 12(16):6931-6954. PubMed ID: 36276650
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma Evaluation via Imaging and Artificial Intelligence.
Yang CM; Shu J
Oncology; 2021; 99(2):72-83. PubMed ID: 33147583
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of cholangiocarcinoma.
Qurashi M; Vithayathil M; Khan SA
Eur J Surg Oncol; 2023 Sep; ():107064. PubMed ID: 37709624
[TBL] [Abstract][Full Text] [Related]
12. Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.
Nagino M
J Gastroenterol; 2012 Nov; 47(11):1165-76. PubMed ID: 22847554
[TBL] [Abstract][Full Text] [Related]
13. EMLI-ICC: an ensemble machine learning-based integration algorithm for metastasis prediction and risk stratification in intrahepatic cholangiocarcinoma.
Ruan J; Xu S; Chen R; Qu W; Li Q; Ye C; Wu W; Jiang Q; Yan F; Shen E; Chu Q; Jia Y; Zhang X; Fu W; Chen J; Timko MP; Zhao P; Fan L; Shen Y
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36259363
[TBL] [Abstract][Full Text] [Related]
14. Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study.
Chansitthichok S; Chamnan P; Sarkhampee P; Lertsawatvicha N; Voravisutthikul P; Wattanarath P
Asian Pac J Cancer Prev; 2020 Apr; 21(4):903-909. PubMed ID: 32334449
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases.
Bakrania A; Joshi N; Zhao X; Zheng G; Bhat M
Pharmacol Res; 2023 Mar; 189():106706. PubMed ID: 36813095
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of Cholangiocarcinoma.
Shin DW; Moon SH; Kim JH
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673043
[TBL] [Abstract][Full Text] [Related]
17. Serum epithelial membrane protein 1 serves as a feasible biomarker in extrahepatic cholangiocarcinoma.
Li X; Yan L; Xue H
Int J Biol Markers; 2021 Sep; 36(3):33-39. PubMed ID: 34569869
[TBL] [Abstract][Full Text] [Related]
18. Liver Transplantation for Cholangiocarcinoma: Insights into the Prognosis and the Evolving Indications.
Panayotova GG; Paterno F; Guarrera JV; Lunsford KE
Curr Oncol Rep; 2020 Apr; 22(5):49. PubMed ID: 32297105
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence CT radiomics to predict early recurrence of intrahepatic cholangiocarcinoma: a multicenter study.
Song Y; Zhou G; Zhou Y; Xu Y; Zhang J; Zhang K; He P; Chen M; Liu Y; Sun J; Hu C; Li M; Liao M; Zhang Y; Liao W; Zhou Y
Hepatol Int; 2023 Aug; 17(4):1016-1027. PubMed ID: 36821045
[TBL] [Abstract][Full Text] [Related]
20. Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma.
Xu L; Wang P; Zhang W; Li W; Liu T; Che X
Front Oncol; 2021; 11():757498. PubMed ID: 34660327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
